Stock listing

OTC:PGBIF PegBio Co., Ltd. Stock

US listing (OTC) of PegBio Co., Ltd. · home listing HKEX:2565

Follow PegBio Co., Ltd. into a list and get an email when it puts out news.

Home listing price · HKEX:2565

$2.23 HKD -0.19 (-8.1%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, HKEX:2565

Past year -96.4% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$2.17 – $2.45 HKDNov 20, 2026
Volume
18.45M sharesNov 20, 2026
Market cap
$918.5M HKDAt the close on Nov 20, 2026 · price × 412.8M shares outstanding
52-week range
$2.17 – $77.00 HKDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$46.70M HKDMedian day 5.22M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
PegBio Co., Ltd. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
HKEX:2565 · Home$2.225 HKD-0.195 (-8.1%)18,454,850$2.32$2.45$2.17$2.42Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · HKEX:2565 · HKD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$2.225-0.195-8.1%$2.32$2.45$2.1718,454,850
$2.42-0.43-15.1%$2.83$2.895$2.4222,498,300
$2.85-0.37-11.5%$3.295$3.38$2.84527,692,900
$3.22-0.03-0.9%$3.625$3.795$3.2259,264,350
$3.25-0.125-3.7%$3.415$3.53$3.2518,404,000
$3.375+0.115+3.5%$3.22$3.44$3.2120,727,450
$3.26-0.24-6.9%$3.445$3.50$3.2417,366,150
$3.50-0.20-5.4%$3.525$3.695$3.42532,160,500
$3.70+0.285+8.3%$3.42$3.73$3.41518,619,000
$3.415+0.045+1.3%$3.155$3.76$3.15537,598,500
$3.37+0.12+3.7%$3.215$3.45$3.21519,345,000
$3.25+0.175+5.7%$3.165$3.345$3.0518,503,200
$3.075-0.61-16.6%$3.20$3.38$3.06519,907,400
$3.685-0.40-9.8%$4.075$4.155$3.66516,835,200
$4.085+0.255+6.7%$4.40$5.29$4.075118,626,050
$3.83+0.25+7.0%$3.58$4.04$3.55522,008,450
$3.58+0.115+3.3%$3.465$3.60$3.4652,764,650
$3.465-0.06-1.7%$3.525$3.715$3.4254,893,800
$3.525+0.005+0.1%$3.30$3.585$3.301,928,498
$3.52+0.12+3.5%$3.70$3.70$3.204,786,250
$3.40-0.285-7.7%$3.735$3.735$3.3654,663,850
$3.685+0.015+0.4%$3.80$3.82$3.6552,455,850
$3.67-0.35-8.7%$4.02$4.045$3.625,181,700
$4.02+0.035+0.9%$4.025$4.515$3.998,528,600
$3.985-0.38-8.7%$4.365$4.495$3.963,930,000
$4.365-0.255-5.5%$4.64$4.665$4.363,606,850
$4.62+0.07+1.5%$4.79$5.335$4.56517,703,699
$4.55-0.14-3.0%$4.75$4.785$4.551,518,000
$4.69-0.17-3.5%$4.95$4.95$4.6151,784,800
$4.86-0.185-3.7%$5.25$5.25$4.832,626,300
$5.045-0.035-0.7%$5.015$5.245$4.87584,400
$5.08+0.18+3.7%$4.89$5.105$4.8988,200
$4.90+0.06+1.2%$5.25$5.25$4.81536,600
$4.84-0.37-7.1%$4.50$5.08$4.50248,550
$5.21+0.035+0.7%$5.28$5.375$5.1853,981,650
$5.175+0.11+2.2%$5.20$5.42$5.084,366,550
$5.065-0.295-5.5%$5.495$5.60$5.0453,018,850
$5.36-0.155-2.8%$5.51$5.515$5.3393,100
$5.515-0.075-1.3%$5.575$5.655$5.5151,615,750
$5.59-0.06-1.1%$5.735$5.74$5.573,024,300
$5.65-0.235-4.0%$5.93$5.93$5.6354,887,550
$5.885+0.09+1.6%$5.805$6.08$5.78512,320,100
$5.795+0.21+3.8%$5.61$5.85$5.617,535,520
$5.585+0.035+0.6%$5.625$5.78$5.515,259,450
$5.55-0.095-1.7%$5.75$5.75$5.5452,850,050
$5.645-0.145-2.5%$5.855$5.855$5.6452,614,750
$5.79-0.02-0.3%$5.935$6.255$5.72511,463,350
$5.81+0.19+3.4%$5.62$5.825$5.4759,897,050
$5.62+0.04+0.7%$5.63$5.845$5.455,840,950
$5.58-0.06-1.1%$5.61$5.795$5.553,988,350
$5.64+0.035+0.6%$5.57$5.96$5.568,481,300
$5.605-0.13-2.3%$5.735$5.735$5.572,368,500
$5.735+0.035+0.6%$5.725$5.92$5.6358,813,200
$5.70+0.115+2.1%$5.90$6.06$5.6015,029,200
$5.585+0.10+1.8%$5.60$5.85$5.419,523,200
$5.485-0.01-0.2%$5.57$5.57$5.441,986,950
$5.495-0.195-3.4%$5.69$5.705$5.493,097,850
$5.69-0.185-3.1%$5.945$5.945$5.683,757,250
$5.875-0.01-0.2%$6.04$6.065$5.7854,748,350
$5.885-0.405-6.4%$6.01$6.28$5.8858,466,300
$6.29+0.33+5.5%$6.02$6.34$5.9158,348,850
$5.96+0.085+1.4%$5.925$6.11$5.755,377,950
$5.875-0.10-1.7%$5.99$6.04$5.874,987,250
$5.975+0.075+1.3%$6.215$6.45$5.97513,109,750
Ticker
OTC:PGBIF
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

What changed lately

Latest news

All PegBio Co., Ltd. news

PegBio Co., Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
19 in the last 12 months · 19 in all · newest Nov 15, 2026 · oldest 2026

Where PegBio Co., Ltd. is listed

ListingExchangeCountryCurrency
HKEX:2565 派格生物醫藥 · Home listingHKEXHong KongHKD
OTC:PGBIF · This pageOTCUnited StatesUSD
OTC:PGBCYOTCUnited StatesUSD

Valuation

Price/book 2.9× against a median of 2.1×: 7th lowest of 9 Biotechnology companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$437.7M HKD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
2.9×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
PegBio Co., Ltd. Class H · HKEX:2565US$117.2MUS$55.83Mn/an/an/a2.9×n/a0.0×n/a
Satellos Bioscience Inc · TSX:MSCLUS$121.9MUS$69.23Mn/an/an/a2.5×n/a0.0×0.49
Alar Pharmaceuticals Inc · TPEX:6785US$121.0MUS$51.66Mn/a568×n/a1.7×n/a0.0×n/a
CANbridge Pharmaceuticals Inc. · HKEX:1228US$120.4MUS$111.5Mn/a13.3×n/an/a−146.4%n/an/a
Atrium Therapeutics, Inc. · NASDAQ:RNAUS$118.4M−US$113.0Mn/a−2.9×n/a0.6×−229.7%0.0×0.76
Adagene, Inc. · NASDAQ:ADAGUS$118.2M−US$3.65Mn/a−0.5×n/a1.1×−229.6%0.1×1.43
STCube, Inc. · KRX:052020US$117.7MUS$71.99Mn/a13.6×n/a2.6×−338.7%0.0×n/a
Curacle Co., Ltd. · KRX:365270US$116.9MUS$99.81Mn/a16.3×n/a3.4×−92.1%0.0×n/a
enGene Therapeutics Inc. · NASDAQ:ENGNUS$116.6M−US$149.7Mn/an/an/a0.5×n/a0.0×1.82
Sinew Pharma, Inc. · TPEX:6634US$114.4MUS$84.21Mn/a59,054×n/a3.6×n/a0.0×n/a
Armata Pharmaceuticals, Inc. · AMEX:ARMPUS$112.7MUS$346.0Mn/a45.8×n/an/an/an/a0.97
Median of the othersUS$117.9MUS$70.61M15.0×2.1×−229.6%0.0×0.97

Forecasts

Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.

Price target
101.80 HKD · Analysts' mean
EPS, year to Dec 2026
-0.44 · 1 analyst

Events

QuarterResultsShare move
Q2 2025Sep 29, 2025−1.4%
Quarter to Jun 30, 2021Aug 31, 2021

Open Events

Financings

RaiseDateIn US dollars
Private placement of new H shares
Closed: HK$80.04M raised · HK$2.985 a share
Use of proceeds: R&D of next-generation pipeline (PB-2309, APGP6, PB-2312) 60%; loan repayment and capital structure 20%; general corporate purposes and working capital 20%
Nov 10, 2026US$10.21M

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in CNY

Income statement

LineFY2025FY2024FY2023FY2022
Revenue0000
Cost of revenue00
Gross profit00
Research and development50.4M95.4M236.7M280.3M
Selling, general and administrative37.0M192.4M55.4M13.2M
Operating income-205.9M-280.9M-277.5M-318.5M
Depreciation and amortization3.74M2.20M3.44M4.39M
EBITDA-202.2M-278.6M-274.0M-314.1M
Interest expense2.78M6.82M11.6M159.0K
Income before tax-208.5M-283.4M-279.2M-306.3M
Net income-208.4M-283.2M-279.0M-306.4M
Earnings per share, basic-0.53-0.73-0.72-0.79

Balance sheet

LineFY2025FY2024FY2023FY2022
Cash and equivalents467.5M28.4M77.1M60.3M
Short-term investments54.5M153.7M263.1M333.5M
Inventory873.0K0
Current assets556.3M190.3M345.5M403.9M
Property, plant and equipment5.10M6.95M
Total assets599.2M218.4M368.1M437.5M
Accounts payable25.2M35.1M90.6M94.0M
Current liabilities141.1M157.7M165.0M125.7M
Total liabilities150.6M166.2M178.2M131.8M
Shareholders' equity448.5M52.2M189.9M300.0M
Shares outstanding391.1M386.0M386.0M386.0M

Cash flow

LineFY2025FY2024FY2023FY2022
Cash from operations-151.9M-183.4M-233.3M-171.4M
Capital spending-3.66M-1.08M-617.0K-3.21M
Free cash flow-155.6M-184.5M-233.9M-174.6M
Cash from investing114.4M101.6M
Cash from financing20.3M148.5M
Change in cash444.9M-48.8M16.9M-171.4M

Open Financials

Filings

FilingDateTypeFiled with
VOLUNTARY ANNOUNCEMENT SUCCESSFUL INCLUSION OF THE GROUP'S CORE PRODUCT PAIDAKANG (VISEPEGENATIDE INJECTION) INTO THE 2026 NRDLNov 15, 2026Operations updateHKEX
FORM OF PROXY FOR USE AT THE 2026 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON THURSDAY, NOVEMBER 26, 2026Nov 11, 2026Proxy formHKEX
NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETINGNov 11, 2026Meeting noticeHKEX
(1) PROPOSED REMOVAL OF AUDITOR (2) PROPOSED APPOINTMENT OF AUDITOR (3) PROPOSED CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERING AND (4) NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETINGNov 11, 2026Meeting noticeHKEX
Next Day Disclosure ReturnNov 10, 2026Next day disclosure returnHKEX
COMPLETION OF PLACING OF NEW H SHARES UNDER GENERAL MANDATENov 10, 2026FinancingHKEX
CANCELLATION OF EXTRAORDINARY GENERAL MEETING AND CANCELLATION OF BOOK CLOSURE PERIODNov 6, 2026Meeting outcomeHKEX
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026Nov 4, 2026Monthly returnHKEX
PLACING OF NEW H SHARES UNDER GENERAL MANDATENov 2, 2026FinancingHKEX
FORM OF PROXY FOR USE AT THE 2026 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON THURSDAY, NOVEMBER 12, 2026Oct 23, 2026Proxy formHKEX
All 19 filings
FilingDateTypeFiled with
NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETINGOct 23, 2026Meeting noticeHKEX
(1) PROPOSED REMOVAL OF AUDITOR (2) PROPOSED APPOINTMENT OF AUDITOR (3) PROPOSED CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERING AND (4) NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETINGOct 23, 2026Meeting noticeHKEX
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026Oct 7, 2026Monthly returnHKEX
2026 Interim ReportSep 23, 2026Interim reportHKEX
CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERINGSep 18, 2026Other filingsHKEX
PROPOSED CHANGE OF AUDITORSep 18, 2026Management or board changeHKEX
VOLUNTARY ANNOUNCEMENT CORE PRODUCT VISEPEGENATIDE INJECTION PASSED THE PRELIMINARY REVIEW IN ACCORDANCE WITH THE 2026 NATIONAL REIMBURSEMENT DRUG LIST ADJUSTMENTJun 29, 2026Operations updateHKEX
Next Day Disclosure ReturnJun 26, 2026Next day disclosure returnHKEX
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONSJun 24, 2026List of directorsHKEX

Open Filings

Cap table

Built by 6ix from PegBio Co., Ltd. Class H’s releases · as of Nov 10, 2026

Common shares
412,815,390
Fully diluted
412,815,390

Fully diluted

LineShares
Common shares412,815,390

Share count over time

CountShares
Nov 22, 2026412,815,390

Open Cap table

Log in to ask 6ix AI your own questions about PegBio Co., Ltd.